|
Real-time Estimate
Cboe BZX
05:59:59 05/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 150.99 USD | -0.15% |
|
+3.67% | +23.04% |
| 03/09 | AbbVie's blood cancer therapy lowers disease progression, death risk in trial | RE |
| 01/09 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
Chart: Technical Analysis
CBOEUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GILD | Delayed | |
CBOE
| GILD | Real-time | |
|
Tradegate
| GIS | Real-time | |
|
London S.E.
| 0QYQ | Delayed | |
|
Boerse Muenchen
| GIS | Real-time | |
|
Mexican S.E.
| GILD * | End-of-day quote | |
|
Xetra
| GIS | Delayed | |
|
Borsa Italiana
| 1GILD | End-of-day quote | |
|
CBOE
| 0QYQ | Real-time | |
|
Swiss Exchange
| GILD | Delayed | |
|
Santiago S.E.
| GILDCL | End-of-day quote | |
|
Lima
| GILDUS | End-of-day quote | |
|
Deutsche Boerse AG
| GIS | Delayed | |
|
Santiago S.E.
| GILD | End-of-day quote | |
|
Börse Stuttgart
| GIS | Delayed | |
|
Wiener Boerse
| GILD | End-of-day quote | |
|
Swiss Exchange
| GILD | Delayed | |
|
CBOE
| Real-time | ||
Sao Paulo
| GILD34 | Delayed | |
Buenos Aires S.E.
| GILD | End-of-day quote | |
|
Buenos Aires S.E.
| GILDD | End-of-day quote | |
Toronto S.E.
| GILD | Delayed | |
|
Deutsche Boerse AG
| GIS0 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 155.8 | 155.8 | 154.98 |
| Spread/Res. | -3.07% | -3.07% | -2.56% |
| Spread/Supp. | +7.53% | +11.66% | +34.72% |
| Support | 140.45 | 135.25 | 112.1 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- GILD Stock
- Charts Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
